Figures & data
![](/cms/asset/55b102ac-24d3-4716-b461-78c9ec264b72/kbie_a_1996509_uf0001_oc.jpg)
Figure 1. The expression level of PD-L1 in MG63, HOS/MNNG, Saos-2, SJSA-1, U2OS, SW1353, 143B, T1-73, KHOS/NP, and hFOB 1.19 cells was determined by Western blotting assay
![Figure 1. The expression level of PD-L1 in MG63, HOS/MNNG, Saos-2, SJSA-1, U2OS, SW1353, 143B, T1-73, KHOS/NP, and hFOB 1.19 cells was determined by Western blotting assay](/cms/asset/bf6aa8ba-251b-4edd-ae62-25dca58cfa95/kbie_a_1996509_f0001_b.gif)
Figure 2. Exosomes were extracted using ultracentrifugation. a. Nanoparticle tracking analysis was used to measure the distribution of particle size (60,000×). b. The ultrastructure of exosomes was visualized by TEM. c. The expression level of HSP70, HSP90, CD63, CD81, PD-1, PD-L1, PD-L2, GRP 94 and GAPDH was detected by Western blotting assay
![Figure 2. Exosomes were extracted using ultracentrifugation. a. Nanoparticle tracking analysis was used to measure the distribution of particle size (60,000×). b. The ultrastructure of exosomes was visualized by TEM. c. The expression level of HSP70, HSP90, CD63, CD81, PD-1, PD-L1, PD-L2, GRP 94 and GAPDH was detected by Western blotting assay](/cms/asset/a81f1366-83d2-4767-8f58-cbba4a957009/kbie_a_1996509_f0002_oc.jpg)
Figure 3. Exosomes extracted from OS cells inactivated Jurkat cells through its loaded PD-L1. a. The production of IFN-γ was determined in MG63 Exosome, Saos-2 Exsome, and hFOB1.19 Exosome by ELISA assay (p < 0.05, p < 0.01). b. Western blotting assay was used to evaluate the expression level of PD-L1 in Jurkat cells treated with PBS, siNC, siPD-L1#1, and siPD-L1#2. c. The secretion of IFN-γ from MG63 cells with or without Exosome and PMA+ionomycn treatment was measured by ELISA assay (p < 0.01)
![Figure 3. Exosomes extracted from OS cells inactivated Jurkat cells through its loaded PD-L1. a. The production of IFN-γ was determined in MG63 Exosome, Saos-2 Exsome, and hFOB1.19 Exosome by ELISA assay (p < 0.05, p < 0.01). b. Western blotting assay was used to evaluate the expression level of PD-L1 in Jurkat cells treated with PBS, siNC, siPD-L1#1, and siPD-L1#2. c. The secretion of IFN-γ from MG63 cells with or without Exosome and PMA+ionomycn treatment was measured by ELISA assay (p < 0.01)](/cms/asset/827b00c1-9d3e-4863-a95e-0f8701d37622/kbie_a_1996509_f0003_b.gif)
Figure 4. PD-L1 induced the growth of OS cells. a. The expression level of HSP70, HSP90, CD9, PD-L1, GRP 94 and GAPDH was determined by Western blotting. b. Cell viability was measured by CCK-8 assay. c-d. The in vivo growth of OS cells was evaluated by xenograft model (p < 0.01). e. Flow cytometry was used to determine the proportion of CD3 + T cells in the tumor tissues (p < 0.01)
![Figure 4. PD-L1 induced the growth of OS cells. a. The expression level of HSP70, HSP90, CD9, PD-L1, GRP 94 and GAPDH was determined by Western blotting. b. Cell viability was measured by CCK-8 assay. c-d. The in vivo growth of OS cells was evaluated by xenograft model (p < 0.01). e. Flow cytometry was used to determine the proportion of CD3 + T cells in the tumor tissues (p < 0.01)](/cms/asset/b45b5533-66c7-497f-ac76-400b3cb4f1a9/kbie_a_1996509_f0004_oc.jpg)
Figure 5. Exosomal PD-L1 induced the growth of OS cells. a-b. The in vivo growth of OS cells was evaluated by xenograft model (p < 0.01). c. Flow cytometry was used to determine the proportion of CD3 + T cells in the tumor tissues (p < 0.05)
![Figure 5. Exosomal PD-L1 induced the growth of OS cells. a-b. The in vivo growth of OS cells was evaluated by xenograft model (p < 0.01). c. Flow cytometry was used to determine the proportion of CD3 + T cells in the tumor tissues (p < 0.05)](/cms/asset/39eb706a-fe86-4ceb-a3c3-be4c176e8975/kbie_a_1996509_f0005_oc.jpg)
Figure 6. Exosomes extracted from PD-L1 positive OS tissues inactivated Jurkat cells. a. Immunohistochemical assay was used to determine the expression level of PD-L1 in the clinical tumor tissues. The Bar length was 25 μm. b. Relationship between the amount of PD-L1-positive exosomes and the expression of PD-L1 in tumor tissues. c. The production of IFN-γ was determined by ELISA assay (p < 0.01)
![Figure 6. Exosomes extracted from PD-L1 positive OS tissues inactivated Jurkat cells. a. Immunohistochemical assay was used to determine the expression level of PD-L1 in the clinical tumor tissues. The Bar length was 25 μm. b. Relationship between the amount of PD-L1-positive exosomes and the expression of PD-L1 in tumor tissues. c. The production of IFN-γ was determined by ELISA assay (p < 0.01)](/cms/asset/729efe1b-fda2-4eb6-8715-9995a3ecc0bf/kbie_a_1996509_f0006_oc.jpg)